To receive credit for this CME, please complete the post-test. A passing score of 60% or higher is required. Participants can retake  or change test  answers as many times as needed to pass by clicking the browser back arrow until you return to the test form. Thank you for your time! We hope that this information was interesting and will be immediately useful in your practice.

Question Title

* 1. When is it most beneficial to immunize with HPV vaccine in order to prevent HPV-related cancers?

Question Title

* 2. Nearly ALL cervical cancers are caused by persistent HPV infection.

Question Title

* 3. Persistent infection with HPV can cause 6 types of cancer, including:

Question Title

* 4. Licensed in 2006, the HPV vaccine is available for use in people ages 9 to 45. The CDC recommends which of the following schedules?

Question Title

* 5. School-based health centers provide an effective means to increase vaccination coverage among adolescents for the following reasons:

Question Title

* 6. School-based health centers (SBHCs) can use the following strategies to facilitate increased awareness among students:

Question Title

* 7. Reducing missed opportunities to vaccinate is an effective way to increase HPV coverage. Which of the following reasons is a true medical contraindication for HPV vaccination? Check all that apply.

Question Title

* 8. If a minor living in New York is believed to be sexually active or at risk for contracting sexually transmitted diseases the minor is permitted to self-consent for the HPV vaccination.

Question Title

* 9. When speaking with parents about HPV vaccination, what conversational style is most effective?

Question Title

* 10. Strategies that increase HPV vaccination coverage include the following practices:

Question Title

* 11. Address

Please print your scored test, scan, and send to cme@upstate.edu as an attachment with the course name in the subject line to receive CMEs. You must attach your course evaluation to the email as well per the instructions on the website.

T